mRNA |
PF-4800567 hydrochloride |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.2 |
mRNA |
bendamustine |
CTRPv2 |
pan-cancer |
AAC |
0.058 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.2 |
mRNA |
BRD-K45681478 |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.2 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
MK-2206 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.2 |
mRNA |
BRD-K44224150 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.2 |
mRNA |
BRD-K37390332 |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.2 |
mRNA |
MLN2238 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.2 |